THURSDAY, April 30, 2009 - 9:00 a.m. ET
HOPKINTON, Mass., April 17 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. will conduct a conference call discussing the company’s first quarter 2009 financial results at 9:00 a.m. ET on Thursday, April 30. Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company’s outlook for the future.
A news release discussing Caliper’s first quarter 2009 financial results will be issued Thursday, April 30 at approximately 7:00 a.m. ET.
Participants please call 888.713.4199 five to ten minutes prior to the call and use the participant passcode of 57691643. International callers can access the call by dialing 617.213.4861 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PHYECL6BR.
A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper’s earnings call for the second quarter of 2009.
Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from April 30 through May 7, dial 888.286.8010 and use the participant passcode of 26367972. International callers can access the playback by dialing 617.801.6888 and using the same participant passcode.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.
CONTACT: Peter McAree, Chief Financial Officer of Caliper Life Sciences,
+1-508-497-2215
Web site: http://www.caliperls.com/
